Valuation: Grifols, S.A.

Market Cap 5.49B 6.28B 5.07B 4.67B 8.8B 605B 9B 60.54B 23.81B 296B 23.59B 23.07B 1,020B P/E 2026 *
12x
P/E 2027 * 8.95x
Enterprise Value 13.88B 15.88B 12.81B 11.81B 22.25B 1,529B 22.74B 153B 60.21B 749B 59.64B 58.34B 2,579B EV / Sales 2026 *
1.81x
EV / Sales 2027 * 1.67x
Free-Float
79.65%
Yield 2026 *
2.86%
Yield 2027 * 3.24%
1 day-0.59%
1 week+1.95%
Current month+1.32%
1 month-0.26%
3 months-5.89%
6 months-14.32%
Current year-15.16%
1 week 8.75
Extreme 8.75
9.18
1 month 8.75
Extreme 8.75
9.18
Current year 8.43
Extreme 8.432
11.7
1 year 8.43
Extreme 8.432
13.7
3 years 6.36
Extreme 6.362
15.92
5 years 6.36
Extreme 6.362
22.64
10 years 6.36
Extreme 6.362
34.31
Manager TitleAgeSince
Chief Executive Officer 57 2024-03-31
Director of Finance/CFO 49 2024-09-15
Compliance Officer 54 2013-12-31
Director TitleAgeSince
Chairman 76 2010-01-24
Director/Board Member 70 2000-04-12
Director/Board Member 62 2015-05-23
Date Insider Type Main position Quantity % Market Cap.
2/26/26 Free

Director

7,679 0.0018%
2/26/26 Free

Director

1,408 0.0005%
2/18/26 Others

Director

7,679 0.0018%
Change 5-day change 1-year change 3-year change Capi.($)
-0.59%+1.95%-24.44%-33.00% 6.28B
-0.33%+1.83%+24.73%-5.89% 68.85B
+0.67%+0.93%+36.86%+194.41% 52.13B
+0.94%+39.60%+39.60%+39.60% 43.46B
-0.68%+0.87%-52.06%-53.86% 41.24B
-1.40%+3.43%+64.81%-25.61% 30.41B
-2.11%-9.45%+97.76%-50.61% 24.53B
+0.51%+0.46%+72.78%+86.41% 23.42B
-5.57%-0.84%-0.11%+189.27% 19.75B
-0.86%-1.99%+70.03%+124.61% 16.57B
Average -0.95%-0.33%+33.00%+46.53% 32.66B
Weighted average by Cap. -0.58%+0.12%+31.46%+45.40%

Financials

2026 *2027 *
Net sales 7.66B 8.77B 7.07B 6.52B 12.28B 844B 12.56B 84.51B 33.24B 414B 32.93B 32.21B 1,424B 8.13B 9.3B 7.5B 6.92B 13.04B 896B 13.32B 89.68B 35.27B 439B 34.94B 34.18B 1,511B
Net income 510M 583M 470M 433M 817M 56.16B 835M 5.62B 2.21B 27.5B 2.19B 2.14B 94.68B 690M 789M 636M 587M 1.11B 75.99B 1.13B 7.61B 2.99B 37.22B 2.96B 2.9B 128B
Net Debt 8.39B 9.6B 7.74B 7.14B 13.45B 925B 13.75B 92.53B 36.4B 453B 36.05B 35.26B 1,559B 8.08B 9.24B 7.45B 6.87B 12.95B 890B 13.24B 89.1B 35.04B 436B 34.72B 33.95B 1,501B
Logo Grifols, S.A.
Grifols, S.A. specializes in the research, development, manufacturing and marketing of therapeutic products and medical devices for use in hospitals and medical analysis laboratories. Net sales break down by family of products and services as follows: - products derived from plasma (86.2%): products for use by the pharmaceutical and biotechnology industries; - diagnostic machines and reagents (8.5%): in vitro hemophilic diagnostic equipment, coagulation analyzers, infectious serology reagents, etc. for use primarily by blood banks and transfusion centers; - hospital products (2.1%): non-biological surgical products, radiology and nutritional products, etc. for use by hospital pharmacies; - other (3.2%): primarily intermediate biological products and subcontracted manufacturing services. Net sales are distributed geographically as follows: Spain (5.6%), European Union (15.9%), the United States and Canada (56.5%) and other (22%).
Employees
25,000
Date Price Change Volume
26-07-17 €9.078 -0.59% 2,101,952
26-07-16 €9.132 +1.24% 2,347,704
26-07-15 €9.020 +2.06% 1,521,096
26-07-14 €8.838 -0.81% 1,716,519
26-07-13 €8.910 +0.07% 1,271,087
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
11
Last Close Price
9.078EUR
Average target price
14.36EUR
Spread / Average Target
+58.21%

Quarterly revenue - Rate of surprise